Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anna Dénes

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Biodiversity Data Journal|February 8, 2024
Taxonomic notes and key to the West Palearctic <i>Antocha</i> (<i>Antocha</i>) Osten Sacken, 1860 (Diptera, Limoniidae) with description of a new species from MoroccoYouness Mabrouki, Andrei Bogdan Terec, Fouzi A Taybi, et al.
Brain & Spine|January 23, 2023
Meningioma classification by immunohistochemistry: A replicability studyOlivia Näslund, Anna Lipatnikova, Anna Dénes, et al.
Brain and Behavior|December 31, 2025
Genetic Risk Factors for Poor Cognitive Outcome Following Brain Insult-A Systematic ReviewTora Dunås, Sophia Leiss, Alba Corell, et al.
Plos One|May 16, 2023
The clinical value of proneural, classical and mesenchymal protein signatures in WHO 2021 adult-type diffuse lower-grade gliomasAnna Dénes, Thomas Olsson Bontell, Hanna Barchéus, et al.
Journal of Neuro-Oncology|November 26, 2022
Changes in clinical management of diffuse IDH-mutated lower-grade gliomas: patterns of care in a 15-year periodCaroline Svenjeby, Louise Carstam, Katja Werlenius, et al.
Brain Pathology (Zurich, Switzerland)|January 3, 2024
Refinement of prognostication for IDH-mutant astrocytomas using DNA methylation-based classificationTeresia Kling, Sandra Ferreyra Vega, Medha Suman, et al.
Neurosurgery|June 26, 2024
The T1/T2 Ratio is Associated With Resectability in Patients With Isocitrate Dehydrogenase-Mutant Astrocytomas Central Nervous System World Health Organization Grades 2 and 3Jonathan Weller, Eddie de Dios, Sophie Katzendobler, et al.
Journal of Neuro-Oncology|May 20, 2025
CDKN2A/B status versus morphology in diagnosing WHO grade 4 IDH-mutated astrocytomas: what is the clinical relevance?Anna Lipatnikova, Teresia Kling, Anna Dénes, et al.
Frontiers in Oncology|January 27, 2022
WHO Grade Loses Its Prognostic Value in Molecularly Defined Diffuse Lower-Grade GliomasLouise Carstam, Alba Corell, Anja Smits, et al.
Neuro-Oncology Advances|February 27, 2026
Proteomics in IDH-mutated diffuse lower-grade glioma: a scoping reviewCarl-Johan Kihlstedt, Anna Dénes, Alireza Mansouri, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Biodiversity Data Journal|February 8, 2024
Taxonomic notes and key to the West Palearctic <i>Antocha</i> (<i>Antocha</i>) Osten Sacken, 1860 (Diptera, Limoniidae) with description of a new species from MoroccoYouness Mabrouki, Andrei Bogdan Terec, Fouzi A Taybi, et al.
Brain & Spine|January 23, 2023
Meningioma classification by immunohistochemistry: A replicability studyOlivia Näslund, Anna Lipatnikova, Anna Dénes, et al.
Brain and Behavior|December 31, 2025
Genetic Risk Factors for Poor Cognitive Outcome Following Brain Insult-A Systematic ReviewTora Dunås, Sophia Leiss, Alba Corell, et al.
Plos One|May 16, 2023
The clinical value of proneural, classical and mesenchymal protein signatures in WHO 2021 adult-type diffuse lower-grade gliomasAnna Dénes, Thomas Olsson Bontell, Hanna Barchéus, et al.
Journal of Neuro-Oncology|November 26, 2022
Changes in clinical management of diffuse IDH-mutated lower-grade gliomas: patterns of care in a 15-year periodCaroline Svenjeby, Louise Carstam, Katja Werlenius, et al.
Brain Pathology (Zurich, Switzerland)|January 3, 2024
Refinement of prognostication for IDH-mutant astrocytomas using DNA methylation-based classificationTeresia Kling, Sandra Ferreyra Vega, Medha Suman, et al.
Neurosurgery|June 26, 2024
The T1/T2 Ratio is Associated With Resectability in Patients With Isocitrate Dehydrogenase-Mutant Astrocytomas Central Nervous System World Health Organization Grades 2 and 3Jonathan Weller, Eddie de Dios, Sophie Katzendobler, et al.
Journal of Neuro-Oncology|May 20, 2025
CDKN2A/B status versus morphology in diagnosing WHO grade 4 IDH-mutated astrocytomas: what is the clinical relevance?Anna Lipatnikova, Teresia Kling, Anna Dénes, et al.
Frontiers in Oncology|January 27, 2022
WHO Grade Loses Its Prognostic Value in Molecularly Defined Diffuse Lower-Grade GliomasLouise Carstam, Alba Corell, Anja Smits, et al.
Neuro-Oncology Advances|February 27, 2026
Proteomics in IDH-mutated diffuse lower-grade glioma: a scoping reviewCarl-Johan Kihlstedt, Anna Dénes, Alireza Mansouri, et al.
Pageof 2